当前位置: 首页 SCI 期刊 Middle East Journal Of Cancer(非官网)
Middle East Journal Of Cancer

Middle East Journal Of CancerSCIE

国际简称:MIDDLE EAST J CANCER  参考译名:中东癌症杂志

  • CiteScore分区

    Q4

  • JCR分区

    Q4

基本信息:
ISSN:2008-6709
E-ISSN:2008-6687
是否OA:开放
是否预警:否
出版信息:
出版地区:Iran, Islamic Republic of
出版商:Shiraz University of Medical Sciences
出版语言:English
研究方向:ONCOLOGY
评价信息:
影响因子:0.4
CiteScore指数:0.8
SJR指数:0.23
SNIP指数:0.19
发文数据:
Gold OA文章占比:0.00%
研究类文章占比:90.63%
年发文量:64
英文简介 期刊介绍 CiteScore数据 JCR分区 常见问题

英文简介Middle East Journal Of Cancer期刊介绍

The Middle East Journal of Cancer (MEJC) is an internationally peer-reviewed journal dedicated to publishing high-quality basic science and clinical research papers. This magazine covers a wide range of fields in cancer research, including cancer cell biology, cancer genetics, tumor virology, tumor immunology, cancer treatment, as well as epidemiology and cancer prevention. MEJC aims to promote the progress of cancer research in the Middle East and even globally, and provide a platform for researchers to publish and exchange the latest research results.

Its characteristic lies in its comprehensive coverage of cancer research, especially in the Middle East region. This journal emphasizes the publication of research that can arouse interdisciplinary interest and encourages the submission of technically solid and experimentally detailed papers. MEJC's academic positioning is to become one of the authoritative journals in the field of cancer research, providing high impact research results for scientists and medical professionals worldwide. In addition, it is of great significance to the cancer research community, as it not only provides a platform for publishing research, but also helps to promote the translation of scientific discoveries into clinical practice. By publishing research from different regions, MEJC has promoted collaboration and knowledge sharing in global cancer research, which has had a positive impact on improving global cancer management.

期刊简介Middle East Journal Of Cancer期刊介绍

《Middle East Journal Of Cancer》该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

  • 预计审稿时间: 12 Weeks
  • SCIE
  • 非预警

Cite Score数据(2024年最新版)Middle East Journal Of Cancer Cite Score数据

  • CiteScore:0.8
  • SJR:0.229
  • SNIP:0.193
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q4 319 / 404

21%

大类:Medicine 小类:Cancer Research Q4 198 / 230

13%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础,针对的是前四年发表的论文的引文。CiteScore的意义在于,它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法,而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

JCR分区Middle East Journal Of Cancer JCR分区

2023-2024 年最新版
按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY ESCI Q4 304 / 322

5.7%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY ESCI Q4 307 / 322

4.81%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

投稿常见问题